HOME >> MEDICINE >> NEWS
Protein marker predicts possible heart damage after chemotherapy

DALLAS, May 18 High levels of troponin I (TNI) protein in the blood helps identify possible heart damage after cancer treatment, according to a report in today's rapid access issue of Circulation: Journal of the American Heart Association.

The report also suggests that tracking TNI levels can help doctors form a heart disease prevention plan for some chemotherapy patients. "Damage to the heart is one of the most worrisome long-term side effects of high-dose chemotherapy," said lead author Daniela Cardinale, M.D., deputy director of the cardiology unit at the European Institute of Oncology in Milan, Italy. "Therefore, it is important to identify biochemical markers that might indicate which patients are at greatest risk and how severe their heart disease might be."

TNI is a protein present exclusively in heart cells. The TNI blood concentration is a well-established marker of heart muscle injury that's widely used to diagnose and treat heart attacks and other acute coronary syndromes.

"Our study is the first to clearly show, in an adult population, that the risk of cardiac events in cancer patients can be predicted by evaluating the TNI release pattern after chemotherapy," Cardinale said.

In cancer patients who have had chemotherapy, physicians usually use extensive testing and expensive monitoring equipment to identify which patients may have cardiac toxicity, Cardinale said. These methods "have low sensitivity, poor predictive value and, in some cases, technical limitations. Moreover, these methods identify cardiac damage only when it has already occurred and, in most cases, is not reversible," she said. "Evaluating TNI value after chemotherapy is an easy, non-invasive, low-cost method that allows us to categorize the risk of cardiac events in cancer patients in the three years following chemotherapy."

Researchers took blood samples of 703 cancer patients to measure TNI soon after high-dose chemotherapy and one month later.
'"/>

Contact: Carole Bullock
carole.bullock@heart.org
214-706-1279
American Heart Association
17-May-2004


Page: 1 2

Related medicine news :

1. Protein that helps skin cancer spread identified by Stanford researchers
2. Proteins found in urine of pregnant women could help diagnose preeclampsia
3. Protein that promotes survival of stem cells might be key to poor leukemia prognosis
4. Protein key could aid search for cancer drugs
5. Lab study: Protein delivered via genetically engineered virus slowed glioblasoma multiforme growth
6. Protein not only aids nerve development, but promotes blood vessel growth, too
7. Protein promotes cancer metastasis and survival
8. Protein helps immune system mount instant strike against deadly flu viruses
9. Protein that predicts tamoxifen resistance is identified
10. Protein identified that may play central role in inflammatory bowel disease
11. Protein implicated in decline of aging hearts

Post Your Comments:
(Date:5/22/2013)... new study suggests that disturbed sleep in adolescents ... greater uncertainly about future success. However, perceived ... to have a protective effect. , Results ... depressed mood and greater uncertainty about future success. ... from teachers were associated with significantly fewer sleep ...
(Date:5/22/2013)... Auburn, AL (PRWEB) May 22, 2013 ... Jr. of Birmingham, Alabama. A University of Alabama graduate, ... its surrounding areas. As a TeethWhiteningforFree.com dentist, he extends ... office for a routine exam and/or check up. Only ... health makes them eligible for whitening treatments. ...
(Date:5/22/2013)... With the health of a growing fetus largely dependent ... that many women become hyperaware of everything that goes into ... on a pregnancy test. At no other time in life ... (like caffeine, alcohol, and nicotine) stronger than during pregnancy. But ... Does this increased awareness during pregnancy extend to the lotions, ...
(Date:5/22/2013)... Peak Solar introduces unique, interactive solar training seminars, which ... make informed buying choices. Research studies tell companies that ... to give them the tools needed to make informed ... Solar training seminars will be introduced onto the website, ... kits . , Poised to help both residential and ...
(Date:5/22/2013)... CA (PRWEB) May 22, 2013 Many problems ... great deal of pain for a patient if left untreated. ... their pain could be easily fixed through occlusal adjustment. ... or neck and back pain should have their dentist check ... change the bite and can lead to problems if the ...
Breaking Medicine News(10 mins):Health News:Parent and teacher support protects teens from sleep problems and depression 2Health News:Dr. James Sanderson, Jr. Of SanDentistry in Hoover, Alabama Joins the TeethWhiteningforFree.com Family 2Health News:Fairhaven Health Launches New PregnancyPlus Natural Deodorant Designed Specifically for Pregnant Women 2Health News:Online Solar Training Seminars Aimed at Informing Consumers 2Health News:Dr. Martin N. Gorman: Make Headaches, Sensitive Teeth and Neck or Back Pain a Thing of the Past 2
(Date:5/22/2013)... , 22. Mai 2013  Grifols, ein ... Barcelona , Spanien, präsentierte ... eine höhere Dosis von PROLASTIN©-C (Alpha1-Proteinasehemmer [human]) ... Alpha1-Antitrypsinmangel (AAT) auf ein Niveau anhebt, das ... Bereichs liegt. ATT-Mangel ist eine lebensbedrohliche, genetische ...
(Date:5/22/2013)... Israel , May 22, 2013  Rosetta ... developer and provider of microRNA-based molecular diagnostics, announces that ... Chief Executive Officer of Rosetta Genomics, will deliver a ... place from June 3-6, 2013 in New York City.  ... 4 th at 2:00 p.m. Eastern time. ...
(Date:5/22/2013)... , May 22, 2013  Medifocus, Inc. (OTCQX: MDFZF and ... , Chief Operating Officer, will present at the Second Annual ... New York City at the Grand ... to begin at 4:00 p.m. EDT and will be available ...   http://wsw.com/webcast/marcum/mfs.v/   For more information and registration, ...
Breaking Medicine Technology:Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 2Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 3Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference 2Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference 3
Cached News: